Invention Grant
- Patent Title: Heteroaryl substituted benzoxazoles
- Patent Title (中): 杂芳基取代的苯并恶唑
-
Application No.: US11763151Application Date: 2007-06-14
-
Publication No.: US07670591B2Publication Date: 2010-03-02
- Inventor: Jonas Malmstrom , David Pyring , Can Slivo , Daniel Sohn , Britt-Marie Swahn , David Wensbo
- Applicant: Jonas Malmstrom , David Pyring , Can Slivo , Daniel Sohn , Britt-Marie Swahn , David Wensbo
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent David M. Gryte
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61K31/443 ; C07D413/04

Abstract:
The present invention relates to novel heteroaryl substituted benzoxazole derivatives and therapeutic uses for such compounds, having the structural formula (Ia) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted benzoxazole derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.
Public/Granted literature
- US20080027051A1 Novel Heteroaryl Substituted Benzoxazoles Public/Granted day:2008-01-31
Information query